البلد: المملكة المتحدة
اللغة: الإنجليزية
المصدر: VMD (Veterinary Medicines Directorate)
Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae
Boehringer Ingelheim Animal Health UK Ltd
QI07AB01
Leptospira canicola, Leptospira grippotyphosa, Leptospira icterohaemorrhagiae
Suspension for injection
POM-V - Prescription Only Medicine – Veterinarian
Dogs
Inactivated Bacterial Vaccine
Authorized
2015-12-10
Revised: September 2020 AN: 01797/2019 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Eurican Lmulti Suspension for Injection 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One dose (1ml) of suspension contains: ACTIVE SUBSTANCES: Inactivated_ Leptospira interrogans _serogroup_ _ and serovar Canicola strain 16070 ......................................................................Activity acc. to Ph. Eur.447* Inactivated_ Leptospira interrogans _serogroup and serovar _ _Icterohaemorrhagiae strain16069 .......................................................................Activity acc. to Ph. Eur.447* Inactivated _Leptospira interrogans _serogroup and serovar_ _Grippotyphosa strain Grippo Mal 1540 ..........................................................Activity acc. to Ph. Eur.447* * 80% protection in hamsters EXCIPIENTS: For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Suspension for injection. Opalescent and homogenous suspension. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Active immunisation of dogs to: - prevent mortality, clinical signs, infection, bacterial excretion, renal carriage and renal lesions caused by _Leptospira_ interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae - prevent mortality* and clinical signs, reduce infection, bacterial excretion, renal carriage and renal lesions caused by _ Leptospira_ interrogans serogroup Canicola serovar Canicola. - prevent mortality*, and reduce clinical signs, infection, bacterial excretion renal carriage and renal lesions caused by _Leptospira_ kirschneri serogroup Grippotyphosa serovar Grippotyphosa. Revised: September 2020 AN: 01797/2019 Page 2 of 5 - prevent mortality, clinical signs, renal infection, bacterial excretion, renal carriage and renal lesions caused by _Leptospira_ _interrogans_ serogroup Icterohaemorrhagiae serovar Copenhageni.** Onset of immunity: 2 weeks after the second injection of the primary v اقرأ الوثيقة كاملة